Skarlis, C.; Angelopoulou, E.; Rentzos, M.; Papageorgiou, S.G.; Anagnostouli, M.
Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions. Int. J. Mol. Sci. 2025, 26, 9398.
https://doi.org/10.3390/ijms26199398
AMA Style
Skarlis C, Angelopoulou E, Rentzos M, Papageorgiou SG, Anagnostouli M.
Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions. International Journal of Molecular Sciences. 2025; 26(19):9398.
https://doi.org/10.3390/ijms26199398
Chicago/Turabian Style
Skarlis, Charalampos, Efthalia Angelopoulou, Michail Rentzos, Sokratis G. Papageorgiou, and Maria Anagnostouli.
2025. "Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions" International Journal of Molecular Sciences 26, no. 19: 9398.
https://doi.org/10.3390/ijms26199398
APA Style
Skarlis, C., Angelopoulou, E., Rentzos, M., Papageorgiou, S. G., & Anagnostouli, M.
(2025). Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions. International Journal of Molecular Sciences, 26(19), 9398.
https://doi.org/10.3390/ijms26199398